IGF1 and pituitary tumor: From 215 cases with evaluable information on pituitary tumor size and IGF-1 levels, patients with macro-adenomas achieved IGF-1 normalization in 138 [77.5% of 178] instances and those with micro-adenomas in 33 [89.2% of 37] cases (Table 1).